The approach would apply to Pfizer's request for a licence to develop the COVID-19 tool.
In terms of the Scheme the board that wants the sale meets its costs, and it's not Pfizer's.
Even the RAP board would would say no to a question: "Oh, we want to buy your company. Would you mind meeting the expenses?"
- Forums
- ASX - By Stock
- RAP
- Why you should vote No...
Why you should vote No..., page-29
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable